Achieving an AIDS-free world: Science and implementation

The Lancet

Volumn 382, Issue 9903, 2013, Pages 1461-1462

  Fauci, Anthony S ^a   Marston, Hilary D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PATIENT CARE; PRIORITY JOURNAL;

EID: 84886801999     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)62042-5     Document Type: Note

References (12)

1. WHO. Global update on HIV treatment 2013: results, impact and opportunities. June, 2013. http://apps.who.int/iris/bitstream/10665/85326/1/ 9789241505734-eng.pdf (accessed Sept 16, 2013).
2. US Department of State. Recognizing the 10th Anniversary of the U.S. President's Plan for Emergency AIDS Relief (PEPFAR). June 18, 2013. http://www.state.gov/r/pa/prs/ps/2013/06/210765.htm (accessed Sept 16, 2013).
3. Gray R, Kigozi G, Kong X, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS 2012; 26: 609-15.
4. Okwundu C, Uthman O, Okoromah C. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev 2012; 7: CD007189.
5. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505.
6. Granich R, Williams B, Montaner J. Fifteen million people on antiretroviral treatment by 2015: treatment as prevention. Curr Opin HIV AIDS 2013; 8: 41-49.
7. Fauci AS, Folkers G. Controlling and ultimately ending the HIV/AIDS pandemic: a feasible goal. JAMA 2010; 304: 350-51.
8. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-infection in Thailand. N Engl J Med 2009; 361: 2209-20.
9. Klein F, Mouquet H, Dosenovic P, Scheid JF, Scharf L, Nussenzweig MC. Antibodies in HIV-1 vaccine development and therapy. Science 2013; 341: 1199-204.
10. Hoot S, McGuire AT, Cohen KW, et al. Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs. PLOS Pathog 2013; 9: 1-14.
11. Kwong P, Mascola J, Nabel G. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning. Nat Rev Immunol 2013; 13: 693-701.
12. Chun TW, Fauci AS. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure. AIDS 2012; 26: 1261-68.